- Home
- DLB vs LNTH Comparison
DLB vs LNTH Comparison
Compare DLB & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLB
- LNTH
- Stock Information
- Founded
- DLB 1965
- LNTH 1956
- Country
- DLB United States
- LNTH United States
- Employees
- DLB N/A
- LNTH N/A
- Industry
- DLB Multi-Sector Companies
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DLB Miscellaneous
- LNTH Health Care
- Exchange
- DLB Nasdaq
- LNTH Nasdaq
- Market Cap
- DLB 7.9B
- LNTH 7.5B
- IPO Year
- DLB 2005
- LNTH 2015
- Fundamental
- Price
- DLB $77.20
- LNTH $79.78
- Analyst Decision
- DLB Strong Buy
- LNTH Strong Buy
- Analyst Count
- DLB 4
- LNTH 5
- Target Price
- DLB $101.75
- LNTH $133.80
- AVG Volume (30 Days)
- DLB 400.7K
- LNTH 1.4M
- Earning Date
- DLB 05-01-2025
- LNTH 05-07-2025
- Dividend Yield
- DLB 1.71%
- LNTH N/A
- EPS Growth
- DLB 36.08
- LNTH N/A
- EPS
- DLB 2.64
- LNTH 3.53
- Revenue
- DLB $1,320,184,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- DLB $6.38
- LNTH $4.96
- Revenue Next Year
- DLB $4.65
- LNTH $10.25
- P/E Ratio
- DLB $29.26
- LNTH $22.59
- Revenue Growth
- DLB 4.03
- LNTH 12.53
- 52 Week Low
- DLB $66.35
- LNTH $74.34
- 52 Week High
- DLB $89.66
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- DLB 55.27
- LNTH 29.82
- Support Level
- DLB $73.19
- LNTH $77.01
- Resistance Level
- DLB $78.28
- LNTH $83.60
- Average True Range (ATR)
- DLB 1.45
- LNTH 3.74
- MACD
- DLB 0.48
- LNTH -2.67
- Stochastic Oscillator
- DLB 81.79
- LNTH 8.68
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.